Modeling Glue

Courtesy Rachel Haridsty Mouse Genome Centre, Medical Research Council, Harwell, UK  MUTT AND JEFF: The Jeff mutant (bottom left), derived from an ethylnitrosourea screen for deaf mutants, has craniofacial abnormalities such as a shortened face when compared with a wild-type mouse (top left). The Jeff mutation maps to mouse chromosome 17 in a region of the mouse genome homolous to human chromosome 2p16-23. A large-scale mouse-mutagenesis program in Harwell, UK, recently turned up two new

Written byLaura Spinney
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A large-scale mouse-mutagenesis program in Harwell, UK, recently turned up two new models for the most common form of childhood deafness. Otitis media (OM), as the name implies, is an inflammation of the middle ear. Although believed to be triggered by infection, studies of twins indicate a complex genetic predisposition.1 Children who have malformed eustachian tubes--those with cleft palate or Down syndrome, for instance--seem to be particularly vulnerable.

When OM is accompanied by the buildup of fluid, it is called OM with effusion, or "glue ear," and most children will experience at least one episode of this in their lives. The condition presents as partial deafness, and affected children cannot hear human speech, which can result in impaired social development. Surgery, which is recommended for the worst cases, involves drilling a tiny hole in the eardrum to allow the fluid to escape. As with all surgeries, however, the procedure carries ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies